News
-
The Medical Research Agency announces a competition for non-commercial clinical trials in the field of psychiatry and neurology (ABM/2021/2).
The main objective of the competition is to develop new diagnostic and therapeutic procedures in the field of psychiatry and neurology in non-commercial clinical trials.
-
MRA will contribute 300 million for implementation of RNA technology in Poland
Prime Minister Mateusz Morawiecki has entrusted the Medical Research Agency with the substantive coordination of matters related to the implementation of production of vaccines based on mRNA technology in Poland. The actions taken are aimed at preparing for possible future pandemics and securing Polish patients.
-
MRA launches support for more specialized Clinical Trial Support Centres
-
Medical Research Agency creates Polish Clinical Research Network
The Medical Research Agency is creating a new quality in clinical trials. After the first competition for funding of Clinical Research Support Centres has been decided, the Agency's activities are accelerating towards the further development of the Network of Polish Centres. Already at the beginning of 2021, a second competition was launched to support the next Centres. At the same time, the President of the Agency for Medical Research Dr. Radosław Sierpiński signed an agreement on the creation of the first Polish Clinical Research Network.
-
Agreement for the internationalization of medical science
-
Results of the call for research and development activity in the scope of non-commercial clinical research - III round
-
MRA will donate PLN 100 million for research in the area of rare diseases
The Medical Research Agency launches the first programme in Central and Eastern Europe worth PLN 100 million for research and development activities, which will be available to patients affected by a disease considered rare or ultra rare.
-
MRA launches nationwide study of new coronavirus mutation
The Medical Research Agency, on behalf of the Minister of Health, in collaboration with the Malopolska Centre for Biotechnology at the Jagiellonian University, is launching a nationwide study to monitor the genetic variation of the SARS-CoV-2 virus in Poland.
-
Who recovered from COVID-19? A nationwide survey is being launched
Medical Research Agency in cooperation with National Institute of Public Health - PZH on behalf of the Minister of Health launches "Nationwide Sero-epidemiological Study COVID-19: OBSER-CO". The project aims to assess the actual prevalence of SARS-CoV-2 virus in Poland.
-
MRA supported the SARSTer project - testing therapeutic options used in the fight against COVID-19
The Medical Research Agency, on behalf of the Minister of Health, has funded a project of researchers from the Societas Polona Epidemiologrum et Medicorum Contagigosorum (PTEiLChZ) who will test the effectiveness and safety of various COVID-19 therapy options used in Poland since the beginning of the epidemic.